Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 462 participants.
Also called NCT07747402
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 462 participants
- Sponsor
- Xi'an International Medical Center Hospital
- Registry
-
NCT07747402
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07747402. Randomized; no masking; primary purpose treatment. Start 2027-01 (anticipated); primary completion 2027-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Insulin icodec
- Lead sponsor
- Xi'an International Medical Center Hospital
Record details
- Record id
cardio:ct-nct07747402- Content hash
372d8bc36b1449f9b1689d3fd125ae041b1634d32d710b6c059ffed93647bd51